Skip to main content
Top
Published in: Endocrine Pathology 3/2008

01-09-2008

Metastatic Small Cell Carcinoma to the Thyroid Gland: a Pathologic and Molecular Study Demonstrating the Origin in the Urinary Bladder

Authors: Soraya Puente, Ana Velasco, Pilar Gallel, Judit Pallares, Luis Perez-Ruiz, Susana Ros, Javier Maravall, Xavier Matias-Guiu

Published in: Endocrine Pathology | Issue 3/2008

Login to get access

Abstract

Small cell carcinomas may occur in the thyroid gland. Infrequently, they are primary tumors, and have been interpreted as variants of medullary thyroid carcinoma. However, the vast majority of small cell carcinomas involving the thyroid gland are metastatic tumors. In some cases, demonstration of the primary tumor is not easy. An example of a small cell carcinoma metastatic to the thyroid is presented in this report. The primary tumor was a small cell carcinoma that occurred as a minor component in a transitional carcinoma of the urinary bladder. The microscopical and immunohistochemical features of both tumors, in the thyroid and the bladder, were identical. Moreover, both tumors exhibited an identical mutation in p53, as well as similar loss of heterozygosity at 10q23 and RASSF1A promoter hypermethylation, clearly indicating that the bladder tumor was the site for the primary tumor of the patient.
Literature
1.
go back to reference Eusebi V, Damiani S, Riva C, Lloyd RV, Capella C. Calcitonin free oat-cell carcinoma of the thyroid gland. Virchows Arch A Pathol Anat Histopathol 417:267–71, 1990.PubMedCrossRef Eusebi V, Damiani S, Riva C, Lloyd RV, Capella C. Calcitonin free oat-cell carcinoma of the thyroid gland. Virchows Arch A Pathol Anat Histopathol 417:267–71, 1990.PubMedCrossRef
2.
go back to reference Matias-Guiu X, DeLellis RA, Moley JF. Medullary thyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, et al., editors. Pathology and genetics of tumors of endocrine organs: WHO classification of tumors. Lyon: IARC; pp. 86–91, 2004. Matias-Guiu X, DeLellis RA, Moley JF. Medullary thyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, et al., editors. Pathology and genetics of tumors of endocrine organs: WHO classification of tumors. Lyon: IARC; pp. 86–91, 2004.
3.
go back to reference Matias-Guiu X, LaGuette J, Puras-Gil AM, Rosai J. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases. Am J Surg Pathol 21:754–62, 1997.PubMedCrossRef Matias-Guiu X, LaGuette J, Puras-Gil AM, Rosai J. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases. Am J Surg Pathol 21:754–62, 1997.PubMedCrossRef
4.
go back to reference Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, et al. Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR. J Endocrinol Invest 28:371–8, 2005.PubMed Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, et al. Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR. J Endocrinol Invest 28:371–8, 2005.PubMed
5.
go back to reference Mendelsohn G, Baylin SB, Bigner SH, Wells SA Jr, Eggleston JC. Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333–41, 1980.PubMedCrossRef Mendelsohn G, Baylin SB, Bigner SH, Wells SA Jr, Eggleston JC. Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333–41, 1980.PubMedCrossRef
6.
go back to reference Tsutsumi Y. Immunohistochemical analysis of calcitonin and calcitonin gene-related peptide in human lung. Hum Pathol 20:896–902, 1989.PubMedCrossRef Tsutsumi Y. Immunohistochemical analysis of calcitonin and calcitonin gene-related peptide in human lung. Hum Pathol 20:896–902, 1989.PubMedCrossRef
7.
go back to reference Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 109:364–71, 1988.PubMed Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 109:364–71, 1988.PubMed
8.
go back to reference Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 103:1172–8, 2005.PubMedCrossRef Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 103:1172–8, 2005.PubMedCrossRef
9.
go back to reference Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101:957–62, 2004.PubMedCrossRef Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101:957–62, 2004.PubMedCrossRef
10.
go back to reference Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 36:718–23, 2005.PubMedCrossRef Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 36:718–23, 2005.PubMedCrossRef
11.
go back to reference Fujita T, Kiyama M, Tomizawa Y, Kohno T, Yokota J. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol 15:927–34, 1999.PubMed Fujita T, Kiyama M, Tomizawa Y, Kohno T, Yokota J. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol 15:927–34, 1999.PubMed
12.
go back to reference Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, et al. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 25:2001–4, 2005.PubMed Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, et al. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 25:2001–4, 2005.PubMed
13.
go back to reference Han B, Mori I, Wang X, Nakamura M, Nakamura Y, Kakudo K. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components. Int J Exp Pathol 86:213–8, 2005.PubMedCrossRef Han B, Mori I, Wang X, Nakamura M, Nakamura Y, Kakudo K. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components. Int J Exp Pathol 86:213–8, 2005.PubMedCrossRef
14.
go back to reference Gallardo A, Matias-Guiu X, Lagarda H, Catasus L, Bussaglia E, Gras E, et al. Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases. Int J Gynecol Pathol 21:268–72, 2002.PubMedCrossRef Gallardo A, Matias-Guiu X, Lagarda H, Catasus L, Bussaglia E, Gras E, et al. Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases. Int J Gynecol Pathol 21:268–72, 2002.PubMedCrossRef
Metadata
Title
Metastatic Small Cell Carcinoma to the Thyroid Gland: a Pathologic and Molecular Study Demonstrating the Origin in the Urinary Bladder
Authors
Soraya Puente
Ana Velasco
Pilar Gallel
Judit Pallares
Luis Perez-Ruiz
Susana Ros
Javier Maravall
Xavier Matias-Guiu
Publication date
01-09-2008
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 3/2008
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-008-9024-4

Other articles of this Issue 3/2008

Endocrine Pathology 3/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.